Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
15281
-
15282
The effect of precrash velocity reduction on occupant response using a human body finite element model
Published 2017“…<p><b>Objective</b>: The objective of this study is to use a validated finite element model of the human body and a certified model of an anthropomorphic test dummy (ATD) to evaluate the effect of simulated precrash braking on driver kinematics, restraint loads, body loads, and computed injury criteria in 4 commonly injured body regions.…”
-
15283
Determination of biochemical indicators (n = 6).
Published 2024“…<p>a: levels of reproductive hormones in serum, in the model, LH, FSH, and PRL levels significantly increased, while GnRH, T, and E<sub>2</sub> levels decreased, indicating a hormonal imbalance compared to controls; b: changes in neurotransmitters in serum, serum levels of 5-HT and NE significantly decreased in the model, with 5-HT reduction being greater than NE. …”
-
15284
-
15285
-
15286
-
15287
S1 Data -
Published 2024“…The two groups of rats were observed and compared for PVT formation at 1, 3 and 5 days after modeling, respectively.</p><p>Results</p><p>A stable rat PVT model was successfully constructed. …”
-
15288
-
15289
BMD analysis of red cell count (A), hematocrit (B) and hemoglobin (C) in males (triangles) and females (circles).
Published 2014“…<p>These parameters were dose-dependently decreased in both genders. Small symbols indicate individual samples, large symbols the group mean; the vertical dotted line indicates the dose (CED) with 5% decrease (CES -0.05) compared to background (a parameter). …”
-
15290
-
15291
-
15292
-
15293
-
15294
-
15295
-
15296
Adverse events in low-dose naltrexone arm.
Published 2024“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
-
15297
CONSORT flow diagram.
Published 2024“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
-
15298
Adverse events in placebo arm.
Published 2024“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
-
15299
Adverse events in gabapentin arm.
Published 2024“…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
-
15300